Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Hypoparathyroidism: Musculoskeletal Manifestations Related to Parathormone Deficiency

Author(s): Maroua Slouma*, Emna Hannech and Imen Gharsallah

Volume 20, Issue 5, 2024

Published on: 24 January, 2024

Page: [488 - 500] Pages: 13

DOI: 10.2174/0115733971267895231227102539

Price: $65

Abstract

Background: Hypoparathyroidism is a rare metabolic disorder that can be responsible for musculoskeletal manifestations.

Aim: We present a systematic review of musculoskeletal manifestations of adult-onset nonsurgical nongenetic hypoparathyroidism.

Methods: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline using the MEDLINE database, including manuscripts describing musculoskeletal manifestations of adult-onset nonsurgical nongenetic hypoparathyroidism.

Results: Musculoskeletal manifestations included myopathy, shoulder disorder, immune-negative non-erosive peripheral arthritis, axial involvement simulating spondylarthritis, and diffuse ligamentous ossifications. An association between hypoparathyroidism and spondyloarthritis or autoimmune diseases is possible. T-cell activation, seen in patients with hypoparathyroidism, may explain the co-occurrence of hypoparathyroidism with other autoimmune diseases.

The treatment of these manifestations is based on calcium and active vitamin D supplementation. Parathyroid hormone may have an anabolic effect on muscle atrophy and muscle weakness. Parathyroid hormone can also promote bone formation and bone resorption by stimulating osteoclast differentiation by increasing RANKL (receptor activator for nuclear factor kappa-B ligand) expression. Therefore, hypoparathyroidism can be responsible for an increase in bone mineral density. However, the risk of fractures does not appear to be reduced due to changes in bone microarchitecture and the high risk of falls. Treatment with parathyroid hormone has been shown to improve bone microarchitecture.

Conclusion: Our review showed that musculoskeletal manifestations are frequent in patients with hypoparathyroidism, including muscular, axial, peripheral articular, and entheseal manifestations.

« Previous Next »
Graphical Abstract

[1]
Kužma M, Jackuliak P, Killinger Z, Payer J. Parathyroid hormone-related changes of bone structure. Physiol Res 2021; 70(S1): S3-S11.
[http://dx.doi.org/10.33549/physiolres.934779]
[2]
Romagnoli C, Brandi ML. Muscle physiopathology in parathyroid hormone disorders. Front Med 2021; 8: 764346.
[http://dx.doi.org/10.3389/fmed.2021.764346] [PMID: 34746197]
[3]
Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 2000; 10(1): 29-33.
[http://dx.doi.org/10.2188/jea.10.29] [PMID: 10695258]
[4]
Clarke BL, Leibson CL, Emerson JA, Ransom JE, Lagast H. Co- morbid medical conditions associated with prevalent hypoparathyroidism: A population-based study. J Bone Miner Res 2011; 26: S182.
[5]
Kim SH, Rhee Y, Kim YM, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One 2020; 15(5): e0232842.
[http://dx.doi.org/10.1371/journal.pone.0232842] [PMID: 32384131]
[6]
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in denmark: A nationwide case finding study. J Bone Miner Res 2015; 30(9): 1738-44.
[http://dx.doi.org/10.1002/jbmr.2501] [PMID: 25753591]
[7]
Clarke BL. Epidemiology and complications of hypoparathyroidism. Endocrinol Metab Clin North Am 2018; 47(4): 771-82.
[http://dx.doi.org/10.1016/j.ecl.2018.07.004] [PMID: 30390812]
[8]
Astor MC, Løvås K, Debowska A, et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab 2016; 101(8): 3045-53.
[http://dx.doi.org/10.1210/jc.2016-1477] [PMID: 27186861]
[9]
Cianferotti L, Marcucci G, Brandi ML. Causes and pathophysiology of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2018; 32(6): 909-25.
[http://dx.doi.org/10.1016/j.beem.2018.07.001] [PMID: 30665552]
[10]
Cianferotti L. Classification of hypoparathyroid disorders. Front Horm Res 2019; 51: 127-38.
[http://dx.doi.org/10.1159/000491043] [PMID: 30641517]
[11]
Siraj N, Hakami Y, Khan A. Medical hypoparathyroidism. Endocrinol Metab Clin North Am 2018; 47(4): 797-808.
[http://dx.doi.org/10.1016/j.ecl.2018.07.006] [PMID: 30390814]
[12]
Wortsman J, Posillico JT, Brown EM, Eisenbarth GS, Mallette L. Case 34-1987. N Engl J Med 1988; 318(13): 857-8.
[http://dx.doi.org/10.1056/NEJM198803313181315] [PMID: 3352669]
[13]
Kumar PG, Laloraya M, She JX. Population genetics and functions of the autoimmune regulator (AIRE). Endocrinol Metab Clin North Am 2002; 31(2): 321-338, vi.
[http://dx.doi.org/10.1016/S0889-8529(01)00011-1] [PMID: 12092453]
[14]
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350(20): 2068-79.
[http://dx.doi.org/10.1056/NEJMra030158] [PMID: 15141045]
[15]
Goswami R, Brown EM, Kochupillai N, et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 2004; 150(1): 9-18.
[http://dx.doi.org/10.1530/eje.0.1500009] [PMID: 14713274]
[16]
Rosa RG, Barros AJS, de Lima ARB, et al. Mood disorder as a manifestation of primary hypoparathyroidism: A case report. J Med Case Reports 2014; 8(1): 326.
[http://dx.doi.org/10.1186/1752-1947-8-326] [PMID: 25280468]
[17]
Roca B, Mínguez C, Sáez-Royuela A, Simón E. Dementia, myopathy, and idiopathic hypoparathyroidism. Postgrad Med J 1995; 71(841): 702-2.
[http://dx.doi.org/10.1136/pgmj.71.841.702-a] [PMID: 7494783]
[18]
Zambelis T, Licomanos D, Leonardos A, Potagas C. Neuromyotonia in idiopathic hypoparathyroidism. Neurol Sci 2009; 30(6): 495-7.
[http://dx.doi.org/10.1007/s10072-009-0140-9] [PMID: 19768367]
[19]
Underbjerg L, Sikjaer T, Rejnmark L. Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort study. Clin Endocrinol 2019; 90(4): 592-600.
[http://dx.doi.org/10.1111/cen.13927] [PMID: 30589959]
[20]
Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of hypoparathyroidism: Etiologies and clinical features. J Clin Endocrinol Metab 2016; 101(6): 2300-12.
[http://dx.doi.org/10.1210/jc.2015-3909] [PMID: 26943721]
[21]
Feldman F. Soft tissue mineralization: Roentgen analysis. Curr Probl Diagn Radiol 1986; 15(3): 166-240.
[http://dx.doi.org/10.1016/0363-0188(86)90003-4] [PMID: 2941237]
[22]
Rubin MR. Skeletal manifestations of hypoparathyroidism. Endocrinol Metab Clin North Am 2018; 47(4): 825-37.
[http://dx.doi.org/10.1016/j.ecl.2018.07.008] [PMID: 30390816]
[23]
Bland JH, Frymoyer JW, Newberg AH, Revers R, Norman RJ. Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum 1979; 9(1): 23-65.
[http://dx.doi.org/10.1016/0049-0172(79)90002-7] [PMID: 386520]
[24]
Wen HY, Schumacher HR Jr, Zhang LY. Parathyroid disease. Rheum Dis Clin North Am 2010; 36(4): 647-64.
[http://dx.doi.org/10.1016/j.rdc.2010.09.002] [PMID: 21092844]
[25]
Barber J, Butler RC, Davie MW, Sewry CA. Hypoparathyroidism presenting as myopathy with raised creatine kinase. Br J Rheumatol 2001; 40(12): 1417-8.
[http://dx.doi.org/10.1093/rheumatology/40.12.1417] [PMID: 11752516]
[26]
Nora DB, Fricke D, Becker J, Gomes I. Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report. Arq Neuropsiquiatr 2004; 62(1): 154-7.
[http://dx.doi.org/10.1590/S0004-282X2004000100028] [PMID: 15122452]
[27]
Shane E, McClane KA, Olarte MR, Bilezikian JP. Hypoparathyroidism and elevated muscle enzymes. Neurology 1980; 30(2): 192-5.
[http://dx.doi.org/10.1212/WNL.30.2.192] [PMID: 7188799]
[28]
Snowdon JA, Macfie AC, Pearce JB. Hypocalcaemic myopathy with paranoid psychosis. J Neurol Neurosurg Psychiatry 1976; 39(1): 48-52.
[http://dx.doi.org/10.1136/jnnp.39.1.48] [PMID: 1255212]
[29]
Syriou V, Kolitsa A, Pantazi L, Pikazis D. Hypoparathyroidism in a patient presenting with severe myopathy and skin rash. Case report and review of the literature. Hormones 2005; 4(3): 161-4.
[http://dx.doi.org/10.14310/horm.2002.11154] [PMID: 16613826]
[30]
Policepatil SM, Caplan RH, Dolan M. Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 2012; 111(4): 173-5.
[PMID: 22970532]
[31]
Watanabe M, Ochi H, Arahata H, et al. Myopathy in autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. Muscle Nerve 2012; 45(6): 904-8.
[http://dx.doi.org/10.1002/mus.23321] [PMID: 22581549]
[32]
Yamaguchi H, Okamoto K, Shooji M, Morimatsu M, Hirai S. Muscle histology of hypocalcaemic myopathy in hypoparathyroidism. J Neurol Neurosurg Psychiatry 1987; 50(6): 817-8.
[http://dx.doi.org/10.1136/jnnp.50.6.817] [PMID: 3612163]
[33]
Akmal M. Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism. Am J Nephrol 1993; 13(1): 61-3.
[http://dx.doi.org/10.1159/000168590] [PMID: 8322842]
[34]
Liu ET, Bristow MR, Stone MJ, Willerson JT. Serum myoglobin, ionized calcium, and parathyroid function during rhabdomyolysis. Arch Intern Med 1983; 143(1): 154-7.
[http://dx.doi.org/10.1001/archinte.1983.00350010164031] [PMID: 6849596]
[35]
Okazaki T, Takuwa Y, Yamamoto M, et al. Ossification of the paravertebral ligaments: A frequent complication of hypoparathyroidism. Metabolism 1984; 33(8): 710-3.
[http://dx.doi.org/10.1016/0026-0495(84)90209-9] [PMID: 6431225]
[36]
Jeon I, Cho KH, Kim SW. Concomitant Fahr’s syndrome and thoracic ossification of the posterior longitudinal ligament caused by idiopathic hypoparathyroidism – case report. BMC Musculoskelet Disord 2019; 20(1): 362.
[http://dx.doi.org/10.1186/s12891-019-2747-1] [PMID: 31391033]
[37]
Sivrioglu K, Ozcakir S, Kamay O. Hypoparathyroidism: A rare cause of spondyloarthropathy. Scand J Rheumatol 2006; 35(6): 494-5.
[http://dx.doi.org/10.1080/03009740600784413] [PMID: 17343263]
[38]
Kajitani TR, da Silva RV, Bonfá E, Pereira RMR. Hypoparathyroidism mimicking ankylosing spondylitis and myopathy: A case report. Clinics 2011; 66(7): 1287-90.
[http://dx.doi.org/10.1590/S1807-59322011000700028] [PMID: 21876989]
[39]
Slouma M, Miri S, Metoui L, Dhahri R, Gharsallah I, Louzir B. Skeletal manifestations of autoimmune hypoparathyroidism. J Clin Rheumatol 2021; 27(5): e168-9.
[http://dx.doi.org/10.1097/RHU.0000000000001307] [PMID: 31977660]
[40]
Adams JE, Davies M. Paravertebral and peripheral ligamentous ossification: An unusual association of hypoparathyroidism. Postgrad Med J 1977; 53(617): 167-72.
[http://dx.doi.org/10.1136/pgmj.53.617.167] [PMID: 404637]
[41]
Salvesen HA, Böe J. Idiopathic hypoparathyroidism; observations on two cases, one complicate by moniliasis and idiopathic steatorrhea and one with an unusual degree of calcium deposition in the bones. Acta Endocrinol 1953; 14(3): 214-26.
[PMID: 13123751]
[42]
Gibberd FB. Idiopathic hypoparathyroidism with unusual bone changes and spastic paraplegia. Eur J Endocrinol 1965; 48(1): 23-30.
[http://dx.doi.org/10.1530/acta.0.0480023] [PMID: 14260807]
[43]
Chaykin LB, Frame B, Sigler JW. Spondylitis: A clue to hypoparathyroidism. Ann Intern Med 1969; 70(5): 995-1000.
[http://dx.doi.org/10.7326/0003-4819-70-5-995] [PMID: 5769633]
[44]
Korkmaz C, Yaşar Ş, Binboğa A. Hypoparathyroidism simulating ankylosing spondylitis. Joint Bone Spine 2005; 72(1): 89-91.
[http://dx.doi.org/10.1016/j.jbspin.2004.08.004] [PMID: 15681258]
[45]
Goswami R, Ray D, Sharma R, et al. Presence of spondyloarthropathy and its clinical profile in patients with hypoparathyroidism. Clin Endocrinol 2008; 68(2): 258-63.
[http://dx.doi.org/10.1111/j.1365-2265.2007.03032.x] [PMID: 17803709]
[46]
Ibn Yacoub Y, Rostom S, Hajjaj-Hassouni N. Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism. Rheumatol Int 2011; 31(5): 681-3.
[http://dx.doi.org/10.1007/s00296-009-1220-0] [PMID: 19855974]
[47]
Jiang L, Dai X, Liu J, Ma L, Yu F. Hypoparathyroidism in a patient with systemic lupus erythematosus coexisted with ankylosing spondylitis: A case report and review of literature. Joint Bone Spine 2010; 77(6): 608-10.
[http://dx.doi.org/10.1016/j.jbspin.2010.02.012] [PMID: 20452805]
[48]
Jakkani RK, Sureka J, Mathew J. Spondyloarthropathy occurring in long-standing idiopathic hypoparathyroidism. Radiol Case Rep 2011; 6(4): 545.
[http://dx.doi.org/10.2484/rcr.v6i4.545] [PMID: 27307930]
[49]
John D, Suthar PP. Radiological features of long-standing hypoparathyroidism. Pol Przegl Radiol Med Nukl 2016; 81: 42-5.
[http://dx.doi.org/10.12659/PJR.896104] [PMID: 26937260]
[50]
Memetoglu O, Ozkan F, Taraktas A, Aktas I, Nazikoglu C. Idiopathic hypoparathyroidism mimicking ankylosing spondylitis: A case report. Acta Reumatol Port 2016; 41(1): 82-5.
[PMID: 27115113]
[51]
Javinani A, Meybodi HR, Jamshidi AR, Gharibdoost F, Kavosi H. Autoimmune polyendocrine syndrome type IIIC and ankylosing spondylitis: A case report. Rheumatology 2017; 2(1): 39-43.
[http://dx.doi.org/10.22631/rr.2017.69997.1015]
[52]
Harzy T, Benbouazza K, Amine B, Rahmouni R, Guedira N, Hajjaj-Hassouni N. Idiopathic hypoparathyroidism and adhesive capsulitis of the shoulder in two first-degree relatives. Joint Bone Spine 2004; 71(3): 234-6.
[http://dx.doi.org/10.1016/S1297-319X(03)00128-3] [PMID: 15182797]
[53]
Walton K, Swinson DR. Acute calcific periarthritis associated with transient hypocalcaemia secondary to hypoparathyroidism. Rheumatology 1983; 22(3): 179-80.
[http://dx.doi.org/10.1093/rheumatology/22.3.179] [PMID: 6871587]
[54]
Bilge ŞY, Korkmaz C. Calcium metabolism disorders simulating rheumatologic diseases. Rheumatol Int 2012; 32(6): 1503-5.
[http://dx.doi.org/10.1007/s00296-011-1804-3] [PMID: 21305295]
[55]
Salvador G, Sanmartí R, Ros I, et al. Idiopathic hypoparathyroidism associated with adult rheumatoid arthritis. Clin Rheumatol 1999; 18(4): 334-6.
[http://dx.doi.org/10.1007/s100670050112] [PMID: 10468176]
[56]
Abugassa S, Nordenström J, Eriksson S, Sjödén G. Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 1993; 76(6): 1617-21.
[PMID: 8501170]
[57]
Hong AR, Lee JH, Kim JH, Kim SW, Shin CS. Effect of endogenous parathyroid hormone on bone geometry and skeletal microarchitecture. Calcif Tissue Int 2019; 104(4): 382-9.
[http://dx.doi.org/10.1007/s00223-019-00517-0] [PMID: 30659307]
[58]
Rupich RC. Hypoparathyroidism and Cortical BMD. J Am Geriatr Soc 1991; 39(5): 533-4.
[http://dx.doi.org/10.1111/j.1532-5415.1991.tb02505.x] [PMID: 2022808]
[59]
Fujiyama K, Kiriyama T, Ito M, et al. Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab 1995; 80(7): 2135-8.
[PMID: 7608266]
[60]
Underbjerg L, Malmstroem S, Sikjaer T, Rejnmark L. Bone status among patients with nonsurgical hypoparathyroidism, autosomal dominant hypocalcaemia, and pseudohypoparathyroidism: A cohort study. J Bone Miner Res 2018; 33(3): 467-77.
[http://dx.doi.org/10.1002/jbmr.3328] [PMID: 29087612]
[61]
Shukla S, Iii TG, Thomas WC Jr. The effect of hypoparathyroidism on the aging skeleton. J Am Geriatr Soc 1990; 38(8): 884-8.
[http://dx.doi.org/10.1111/j.1532-5415.1990.tb05704.x] [PMID: 2387952]
[62]
Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP. Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 2010; 21(11): 1927-34.
[http://dx.doi.org/10.1007/s00198-009-1149-x] [PMID: 20094706]
[63]
Chen Q, Kaji H, Iu MF, et al. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 2003; 88(10): 4655-8.
[http://dx.doi.org/10.1210/jc.2003-030470] [PMID: 14557436]
[64]
Drinka PJ. The skeleton in hypoparathyroidism. J Am Geriatr Soc 1991; 39(5): 533-3.
[http://dx.doi.org/10.1111/j.1532-5415.1991.tb02504.x] [PMID: 2022807]
[65]
Chan FKW, Tiu SC, Choi KL, Choi CH, Kong APS, Shek CC. Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 2003; 88(7): 3155-9.
[http://dx.doi.org/10.1210/jc.2002-021388] [PMID: 12843159]
[66]
Rubin MR, Bilezikian JP. Hypoparathyroidism: Clinical features, skeletal microstructure and parathyroid hormone replacement. Arq Bras Endocrinol Metabol 2010; 54(2): 220-6.
[http://dx.doi.org/10.1590/S0004-27302010000200019] [PMID: 20485912]
[67]
Rubin MR, Dempster DW, Zhou H, et al. Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 2008; 23(12): 2018-24.
[http://dx.doi.org/10.1359/jbmr.080803] [PMID: 18684087]
[68]
Laway BA, Goswami R, Singh N, Gupta N, Seith A. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol 2006; 64(4): 405-9.
[http://dx.doi.org/10.1111/j.1365-2265.2006.02479.x] [PMID: 16584512]
[69]
Orr-Walker B, Harris R, Holdaway IM, Foote G, Reid IR. High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism. Postgrad Med J 1990; 66(782): 1061-3.
[http://dx.doi.org/10.1136/pgmj.66.782.1061] [PMID: 2084655]
[70]
Marcucci G, Cianferotti L, Brandi ML. Clinical presentation and management of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2018; 32(6): 927-39.
[http://dx.doi.org/10.1016/j.beem.2018.09.007] [PMID: 30665553]
[71]
Chawla H, Saha S, Kandasamy D, Sharma R, Sreenivas V, Goswami R. Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up. J Clin Endocrinol Metab 2017; 102(1): 251-8.
[PMID: 27813708]
[72]
Cianferotti L, Cipriani C, Corbetta S, et al. Bone quality in endocrine diseases: Determinants and clinical relevance. J Endocrinol Invest 2023; 46(7): 1283-304.
[http://dx.doi.org/10.1007/s40618-023-02056-w] [PMID: 36918505]
[73]
Saha S, Mannar V, Kandasamy D, Sreenivas V, Goswami R. Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism. J Endocrinol Invest 2022; 45(9): 1777-86.
[http://dx.doi.org/10.1007/s40618-022-01818-2] [PMID: 35585296]
[74]
Rosen RA, Deshmukh SM. Growth arrest recovery lines in hypoparathyroidism. Radiology 1985; 155(1): 61-2.
[http://dx.doi.org/10.1148/radiology.155.1.3975421] [PMID: 3975421]
[75]
Yoon SH, Grynpas M, Mitchell J. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy. Bone 2019; 121: 232-42.
[http://dx.doi.org/10.1016/j.bone.2019.01.028] [PMID: 30716510]
[76]
David K, Moyson C, Vanderschueren D, Decallonne B. Long-term complications in patients with chronic hypoparathyroidism: A cross-sectional study. Eur J Endocrinol 2019; 180(1): 71-8.
[77]
Ueda T, Tsurutani Y, Katsuragawa S, Saito J. Type 2 diabetes mellitus complicated with idiopathic hypoparathyroidism where poor glycaemic control was associated with low adherence to exercise and medication due to hypocalcaemia. BMJ Case Rep 2019; 12(12): e232553.
[http://dx.doi.org/10.1136/bcr-2019-232553] [PMID: 31857291]
[78]
Hakami Y, Khan A. Hypoparathyroidism. Front Horm Res 2019; 51: 109-26.
[http://dx.doi.org/10.1159/000491042] [PMID: 30641528]
[79]
Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2012; 26(4): 517-22.
[http://dx.doi.org/10.1016/j.beem.2012.01.004] [PMID: 22863393]
[80]
Liu MF, Chen FF, Hsiue TR, Liu CC. Disseminated zygomycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 2000; 19(4): 311-4.
[http://dx.doi.org/10.1007/s100670070052] [PMID: 10941815]
[81]
Isaia GC, Casalis S, Grosso I, Molinatti PA, Tamone C, Sategna-Guidetti C. Hypoparathyroidism and co-existing celiac disease. J Endocrinol Invest 2004; 27(8): 778-81.
[http://dx.doi.org/10.1007/BF03347523] [PMID: 15636434]
[82]
Chakravarty SD, Markenson JA. Rheumatic manifestations of endocrine disease. Curr Opin Rheumatol 2013; 25(1): 37-43.
[http://dx.doi.org/10.1097/BOR.0b013e32835b4f3f] [PMID: 23159916]
[83]
Schen RJ. Unusual manifestation of hypocalcaemia. BMJ 1979; 2(6190): 610.
[http://dx.doi.org/10.1136/bmj.2.6190.610-d] [PMID: 497735]
[84]
Sohail A, Maan MA, Khan M, Masood Q. Isolated ligamentum flavum ossification in primary hypoparathyroidism. Surg Neurol Int 2018; 9(1): 4.
[http://dx.doi.org/10.4103/sni.sni_364_17] [PMID: 29399376]
[85]
Bollerslev J, Rejnmark L, Marcocci C, et al. European society of endocrinology clinical guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 2015; 173(2): G1-G20.
[http://dx.doi.org/10.1530/EJE-15-0628] [PMID: 26160136]
[86]
Hajiroussou VJ. Hypoparathyroidism associated with systemic lupus erythematosus. Postgrad Med J 1981; 57(671): 597-8.
[http://dx.doi.org/10.1136/pgmj.57.671.597] [PMID: 7329900]
[87]
Edmonds ME, Saunders A, Sturrock RD. Rheumatoid arthritis associated with hypoparathyroidism and Sjögren’s syndrome. J R Soc Med 1979; 72(11): 856-8.
[http://dx.doi.org/10.1177/014107687907201114] [PMID: 552452]
[88]
Ünverdi S, Öztürk MA, Inal S, et al. Idiopathic hypoparathyroidism mimicking diffuse idiopathic skeletal hyperostosis. J Clin Rheumatol 2009; 15(7): 361-2.
[http://dx.doi.org/10.1097/RHU.0b013e3181bb9865] [PMID: 20009974]
[89]
Tay D, Cremers S, Bilezikian JP. Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism – translating the pharmacology. Br J Clin Pharmacol 2018; 84(2): 252-67.
[http://dx.doi.org/10.1111/bcp.13455] [PMID: 29049872]
[90]
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999; 104(4): 439-46.
[http://dx.doi.org/10.1172/JCI6610] [PMID: 10449436]
[91]
Silva BC. Skeletal and nonskeletal consequences of hypoparathyroidism. Arch Endocrinol Metab 2022; 66(5): 642-50.
[http://dx.doi.org/10.20945/2359-3997000000553] [PMID: 36382753]
[92]
Slouma M, Abbes M, Dhahri R, et al. Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture. Clin Rheumatol 2021; 40(2): 775-82.
[http://dx.doi.org/10.1007/s10067-020-05281-3] [PMID: 32666178]
[93]
Silva BC, Rubin MR, Cusano NE, Bilezikian JP. Bone imaging in hypoparathyroidism. Osteoporos Int 2017; 28(2): 463-71.
[http://dx.doi.org/10.1007/s00198-016-3750-0] [PMID: 27577725]
[94]
Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study. J Bone Miner Res 2011; 26(10): 2358-70.
[http://dx.doi.org/10.1002/jbmr.470] [PMID: 21773992]
[95]
Winer KK, Ko CW, Reynolds JC, et al. Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003; 88(9): 4214-20.
[http://dx.doi.org/10.1210/jc.2002-021736] [PMID: 12970289]
[96]
Rubin MR, Dempster DW, Sliney J Jr, et al. PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res 2011; 26(11): 2727-36.
[http://dx.doi.org/10.1002/jbmr.452] [PMID: 21735476]
[97]
Cipriani C, Pepe J, Silva BC, et al. Comparative effect of rhPTH (1-84) on bone mineral density and trabecular bone score in hypoparathyroidism and postmenopausal osteoporosis. J Bone Miner Res 2018; 33(12): 2132-9.
[http://dx.doi.org/10.1002/jbmr.3554] [PMID: 30088838]
[98]
Mäkitie O, Sochett EB, Bondestam S, Sipilä I, Perheentupa J. Bone health in autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED): Findings in 25 adults. Clin Endocrinol 2006; 64(5): 489-94.
[http://dx.doi.org/10.1111/j.1365-2265.2006.02495.x] [PMID: 16649965]
[99]
Krishnan V, Ma YL, Chen CZ, et al. Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism. Br J Pharmacol 2018; 175(2): 262-71.
[http://dx.doi.org/10.1111/bph.14028] [PMID: 28898923]
[100]
Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L. PTH replacement therapy of hypoparathyroidism. Osteoporos Int 2013; 24(5): 1529-36.
[http://dx.doi.org/10.1007/s00198-012-2230-4] [PMID: 23184178]
[101]
Cusano NE, Rubin MR, Sliney J Jr, Bilezikian JP. Mini-review: New therapeutic options in hypoparathyroidism. Endocrine 2012; 41(3): 410-4.
[http://dx.doi.org/10.1007/s12020-012-9618-y] [PMID: 22311174]
[102]
Sikjaer T, Rejnmark L, Thomsen JS, et al. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): A randomized controlled study. J Bone Miner Res 2012; 27(4): 781-8.
[http://dx.doi.org/10.1002/jbmr.1493] [PMID: 22161686]
[103]
Cipriani C, Abraham A, Silva BC, et al. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism. Endocrine 2017; 55(2): 591-8.
[http://dx.doi.org/10.1007/s12020-016-1101-8] [PMID: 27757772]
[104]
Rubin MR, Zwahlen A, Dempster DW, et al. Effects of parathyroid hormone administration on bone strength in hypoparathyroidism. J Bone Miner Res 2016; 31(5): 1082-8.
[http://dx.doi.org/10.1002/jbmr.2777] [PMID: 26724790]
[105]
Sumida K, Ubara Y, Hoshino J, et al. Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: A prospective study. Osteoporos Int 2016; 27(4): 1441-50.
[http://dx.doi.org/10.1007/s00198-015-3377-6] [PMID: 26525045]
[106]
Rubin MR, Cusano NE, Fan WW, et al. Therapy of hypoparathyroidism with PTH(1–84): A prospective six year investigation of efficacy and safety. J Clin Endocrinol Metab 2016; 101(7): 2742-50.
[http://dx.doi.org/10.1210/jc.2015-4135] [PMID: 27144931]
[107]
Lakatos P, Bajnok L, Lagast H, Valkusz Z. An open-label extension study of parathyroid hormone rhPTH (1-84) in adults with hypoparathyroidism. Endocr Pract 2016; 22(5): 523-32.
[http://dx.doi.org/10.4158/EP15936.OR] [PMID: 26684150]
[108]
Misof BM, Roschger P, Dempster DW, et al. PTH (1-84) Administration in hypoparathyroidism transiently reduces bone matrix mineralization. J Bone Miner Res 2016; 31(1): 180-9.
[http://dx.doi.org/10.1002/jbmr.2588] [PMID: 26111772]
[109]
Gafni RI, Guthrie LC, Kelly MH, et al. Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism. J Bone Miner Res 2015; 30(11): 2112-8.
[http://dx.doi.org/10.1002/jbmr.2555] [PMID: 25990370]
[110]
Clarke BL. Bone disease in hypoparathyroidism. Arq Bras Endocrinol Metabol 2014; 58(5): 545-52.
[http://dx.doi.org/10.1590/0004-2730000003399] [PMID: 25166046]
[111]
Hamny I, Chanson P, Borson-Chazot F. New directions in the treatment of hypoparathyroidism. Ann Endocrinol 2023; 84(4): 460-5.
[http://dx.doi.org/10.1016/j.ando.2023.04.001] [PMID: 37080533]
[112]
Formenti AM, Tecilazich F, Giubbini R, Giustina A. Risk of vertebral fractures in hypoparathyroidism. Rev Endocr Metab Disord 2019; 20(3): 295-302.
[http://dx.doi.org/10.1007/s11154-019-09507-x] [PMID: 31471845]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy